RELEVANCE OF PRINCIPLES FOR IMPROVING LABORATORY DIAGNOSIS AND PREVENTION OF BOTULISM

Authors

  • Karima Abdurakhmonova,Khabibakhon Rikhsivoeva,Shokhista Khojinazarova,Noila Ochildieva,Durdoba Ro‘ziqulova Assistant of the Department of Microbiology, Virology, and Immunology at TSMU ,Student of the Faculty of Dentistry at TSMU Author

DOI:

https://doi.org/10.5281/zenodo.20516670

Keywords:

Botulism, diagnosis, treatment, food, poisoning, intoxication, poison center rehabilitation.

Abstract

Botulinum neurotoxin is the cause of botulism, a potentially fatal paralytic illness. A variety of anaerobic spore-forming bacteria, such as Clostridium botulinum groups I and II, Clostridium butyricum and Clostridium baratii, produce human pathogenic neurotoxins of types A, B, E, and F. The identification of botulinum neurotoxin in the patient is the basis for the standard laboratory diagnosis of botulism. The diagnosis is confirmed if toxin-producing clostridia are found in the patient or the car. The mouse lethality test provides the basis for neurotoxic detection. Although quick and sensitive in vitro tests have been created, they have not yet undergone the necessary validation on food and clinical matrices. Effective isolation and identification technologies are inadequate, and C. botulinum culture techniques are underdeveloped. Although molecular methods that target the neurotoxic genes are perfect for identifying and detecting C. botulinum, they should not be utilized in isolation as they do not detect biologically active neurotoxin. In addition to providing a quick diagnosis, laboratory botulism diagnostics should focus on improving our knowledge of the disease's epidemiology and prevention. As a result, it is important to regularly separate the organisms that produce toxins from both the patient and the vehicle. It is necessary to identify the isolates' genetic characteristics and physiological group.

References

1.Lindström M, Korkeala H. Laboratory diagnostics of botulism. Clin Microbiol Rev. 2006 Apr;19(2):298-314.

2.Akbulut D, Grant KA, McLauchlin J. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J Clin Microbiol. 2005 Sep;43(9):4342-8.

3.Lonati D, Schicchi A, Crevani M, Buscaglia E, Scaravaggi G, Maida F, Cirronis M, Petrolini VM, Locatelli CA. Foodborne Botulism: Clinical Diagnosis and Medical Treatment. Toxins. 2020; 12(8):509. https://doi.org/10.3390/toxins12080509

4.Jeremy Sobel, Agam K Rao, Making the Best of the Evidence: Toward National Clinical Guidelines for Botulism, Clinical Infectious Diseases, Volume 66, Issue suppl_1, 15 January 2018, Pages S1–S3, https://doi.org/10.1093/cid/cix829

5.Kobaidze K, Wiley Z. Botulism in the 21st Century: A Scoping Review. Brown Hospital Medicine. 2023;2(2). doi:10.56305/001c.72707.

6.Anniballi, F.; Auricchio, B.; Fiore, A.; Lonati, D.; Locatelli, C.A.; Lista, F.; Fillo, F.; Mandarino, G.; De Medici, D. Botulism in Italy, 1986 to 2015. EuroSurveilance 2017, 22, 30550.

7.Scalfaro, C.; Auricchio, B.; Anniballi, F.; De Medici, D. Foodborne botulism: An evolving public health challenge. Infect. Dis. 2019, 51, 97–101.

8.Rasetti-Escargueil, C.; Lemichez, E. Public Health risk associated with botulism as foodborne zoonoses. Toxins 2020, 12, 17.

9.Rossetto, O.; Pirazzini, M.; Lista, F.; Montecucco, C. The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs. Cell Microbiol. 2019, 21, e13037.

10.Thirunavukkarasu, N.; Johnson, E.; Pillai, S.; Hodge, D.; Stanker, L.; Wentz, T.; Singh, B.; Venkateswaran, K.; McNutt, P.; Adler, M.; et al. Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance. Front. Bioeng. Biotechnol. 2018, 6, 80.

11.Yu, P.A.; Lin, N.H.; Mahon, B.E.; Sobel, J.; Yu, Y.; Mody, K.M.; Gu, W.; Clements, J.; Kim, H.; Rao, A.K. Safety and Improved Clinical Outcomes in Patients Treated with New Equine-Derived Heptavalent Botulinum Antitoxin. Clin. Infect. Dis. 2017, 66, S57–S64.

12.Badell, M.L.; Rimawi, B.H.; Rao, A.K.; Jamieson, D.J.; Rasmussen, S.; Meaney-Delman, D. Botulism During Pregnancy and the Postpartum Period: A Systematic Review. Clin. Infect. Dis. 2017, 66, S30–S37.

13.Rao AK, Lin NH, Griese SE, Chatham-Stephens K, Badell ML, Sobel J. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks. Clin Infect Dis 2017; 66:S38–42.

14.Chatham-Stephens K, Fleck-Derderian S, Johnson SD, et al. Clinical features of foodborne and wound botulism: a systematic review of the literature, 1932–2015. Clin Infect Dis 2017; 66:S11–6.

15.McCrickard L, Marlow M, Self JL, et al. Notes from the Field: Botulism Outbreak from Drinking Prison-Made Illicit Alcohol in a Federal Correctional Facility — Mississippi, June 2016. MMWR Morb Mortal Wkly Rep. 2017;65(52):1491-1492. doi:10.15585/​mmwr.mm6552a8

16.Parameswaran L, Rao A, Chastain K, et al. A Case of Adult Intestinal Toxemia Botulism During Prolonged Hospitalization in an Allogeneic Hematopoietic Cell Transplant Recipient. Clinical Infectious Diseases. 2017;66(suppl_1):S99-S102. doi:10.1093/​cid/​cix847

17.Rao AK, Lin NH, Griese SE, Chatham-Stephens K, Badell ML, Sobel J. Clinical Criteria to Trigger Suspicion for Botulism: An Evidence-Based Tool to Facilitate Timely Recognition of Suspected Cases During Sporadic Events and Outbreaks. Clinical Infectious Diseases. 2017;66(suppl_1):S38-S42. doi:10.1093/​cid/​cix814

18.Harris RA, Anniballi F, Austin JW. Adult Intestinal Toxemia Botulism. Toxins. 2020;12(2):81. doi:10.3390/​toxins12020081. PMID:31991691

19.Sobel J, Rao AK. Making the Best of the Evidence: Toward National Clinical Guidelines for Botulism. Clinical Infectious Diseases. 2017;66(suppl_1):S1-S3. doi:10.1093/​cid/​cix829

20.Griese SE, Kisselburgh HM, Bartenfeld MT, et al. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review. Clinical Infectious Diseases. 2017;66(suppl_1):S17-S29. doi:10.1093/​cid/​cix812 Badell ML,

21.Rimawi BH, Rao AK, Jamieson DJ, Rasmussen S, Meaney-Delman D. Botulism During Pregnancy and the Postpartum Period: A Systematic Review. Clinical Infectious Diseases. 2017;66(suppl_1):S30-S37. doi:10.1093/​cid/​cix813

22.Akbulut, D., K. A. Grant, and J. McLauchlin. 2005. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J. Clin. Microbiol. 43:4342-4348.

23.Ahn-Yoon, S., T. R. De Cory, and R. A. Durst. 2004. Ganglioside-liposome immunoassay for the detection of botulinum toxin. Anal. Bioanal. Chem. 378:68-75.

24.Qureshi IA, Qureshi MA, Rauf Afzal M, et al. Black Tar Heroin Skin Popping as a Cause of Wound Botulism. Neurocrit Care. 2017;27(3):415-419. doi:10.1007/​s12028-017-0415-6

25.Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR Recomm Rep. 2021;70(2):1-30. doi:10.15585/​mmwr.rr7002a1

Downloads

Published

2026-06-03